Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1995
10/26/1995WO1995028172A1 Human bone stimulating factor
10/26/1995WO1995028171A1 Treatment of autonomic nerve dysfunction with botulinum toxin
10/26/1995WO1995028170A1 Icam-1/lfa-1 short-chain peptides and method of using same
10/26/1995WO1995028169A1 Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment
10/26/1995WO1995028167A1 Methods of treating disease using sertoli cells and allografts or xenografts
10/26/1995WO1995028166A2 Method for implanting encapsulated cells in a host
10/26/1995WO1995028161A1 Method of attenuation of nervous system damage
10/26/1995WO1995014091A3 Compositions and methods for utilizing conditionally lethal genes
10/26/1995DE4447484A1 APO-1 inhibitor compsn. inhibits apoptosis
10/26/1995DE4410997A1 Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktionen Pharmaceutical drugs for the prevention and treatment of endothelial dysfunction
10/26/1995CA2189028A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995CA2188316A1 Recombinant pgp3, methods of preparation and use in diagnosis and therapy
10/26/1995CA2188287A1 Icam-1/lfa-1 short-chain peptides and method of using same
10/26/1995CA2188182A1 Conserved t-cell receptor sequences
10/26/1995CA2188180A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995CA2188172A1 Human bone stimulating factor
10/26/1995CA2188162A1 Methionine sulfone and s-substituted cysteine sulfone derivatives as enzyme inhibitors
10/26/1995CA2187945A1 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy
10/26/1995CA2187938A1 Use of g-csf to reduce acute rejection
10/26/1995CA2187818A1 Gene delivery fusion proteins
10/26/1995CA2187770A1 Process for producing dendritic cells, cells thus produced and container for carrying out this process
10/26/1995CA2187768A1 Aqueous solvent encapsulation method, apparatus and microcapsules
10/26/1995CA2187642A1 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis
10/26/1995CA2187526A1 Methods of use of uncoated gel particles
10/26/1995CA2187451A1 Aziridine derivatives, their production and use
10/26/1995CA2187335A1 Method for implanting encapsulated cells in a host
10/26/1995CA2186900A1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines
10/26/1995CA2186639A1 Cell-cycle regulatory proteins, and uses related thereto
10/26/1995CA2183991A1 Tachykinin antagonists
10/26/1995CA2147797A1 Method for the removal of viruses from protein solutions
10/25/1995EP0678744A2 Method for detecting urinary tumor associated antigens
10/25/1995EP0678577A2 Method for the production of recombinant human LH-RH receptor proteins
10/25/1995EP0678523A1 Recombinant anti-hiv antibody and preparation thereof
10/25/1995EP0678522A1 Insulin analogs
10/25/1995EP0678299A2 Pharmaceutical compositions containing one or more of gamma-linolenic acid dihomogamma linolenic and an arachidonic acid
10/25/1995EP0678122A1 Recombinant anti-vla4 antibody molecules
10/25/1995EP0678121A1 Methods and reagents for inhibiting furin endoprotease
10/25/1995EP0678101A1 Growth differentiation factor-9
10/25/1995EP0678100A1 Synthetic amphipathic peptides with antimicrobial activity
10/25/1995EP0678099A1 New peptides
10/25/1995EP0678098A1 Pyrrolidine and thiazolidine derivatives, their preparation and drugs containing same
10/25/1995EP0678089A1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders.
10/25/1995EP0678088A1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders.
10/25/1995EP0678031A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
10/25/1995EP0678029A1 Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
10/25/1995EP0678028A1 Dna encoding a human betaine/gaba transporter and uses thereof
10/25/1995EP0678018A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
10/25/1995EP0433378B1 ALLELIC VARIANTS OF $i(PLASMODIUM FALCIPARUM) MEROZOITE SURFACE ANTIGEN
10/25/1995CN1110865A Amino acid derivative
10/25/1995CN1110605A Method of treating fungal infections
10/24/1995US5461146 Enzyme inhibitor protecting nerve cells from degeneration
10/24/1995US5461142 Phosphorylated derivatives of cardiodilatin/ANF peptides
10/24/1995US5461058 Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
10/24/1995US5461039 Method for treating hypertension employing a cholesterol lowering drug
10/24/1995US5461035 Short peptides with insulin activity
10/24/1995US5461034 Osteogenic growth polypeptides identified from regenerating bone marrow
10/24/1995US5461033 Administering transforming growth factor-beta containing acid casein fraction isolated from bovine milk to treat crohn's disease
10/24/1995US5461031 Monomeric insulin analog formulations
10/24/1995US5461030 Compositions and methods for enhancing wound healing
10/24/1995US5461029 Method of treating herpes viral infections using HBNF and MK proteins
10/24/1995US5460967 Recycle process for the production of low-cost soluble collagen
10/24/1995US5460961 Human myeloperoxidase and its therapeutic application
10/24/1995US5460959 Transduced fibroblasts
10/24/1995US5460956 Method for preparing interferon alpha-2 crystals
10/24/1995US5460953 Vectors and compounds for expression of glycosylation mutants of human protein C
10/24/1995US5460951 Bone-related carboxypeptidase-like protein and process for its production
10/24/1995US5460945 Device and method for analysis of blood components and identifying inhibitors and promoters of the inflammatory response
10/24/1995US5460832 Skin cosmetic having an egg white enzyme hydrolysate with hyaluronic acid synthesis promoting activity
10/24/1995US5460831 Targeted transfection nanoparticles
10/24/1995US5460830 Biochemically active agents for chemical catalysis and cell receptor activation
10/24/1995US5460812 Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
10/24/1995US5460811 Mature human fibroblast interferon
10/24/1995US5460810 Method for maintaining gut epithelial cells by treatment with a cytokine such as interleukin 11
10/24/1995US5460801 Inhibition of small cell lung cancer cell growth in vivo using monoclonal antibody
10/24/1995US5460785 Direct labeling of antibodies and other protein with metal ions
10/24/1995CA1337407C Dimeric peptides having a stimulatory effect on haemopoiesis and a process for their preparation
10/24/1995CA1337400C Inhibitors of neutral endopeptidase
10/21/1995CA2121737A1 An antihypoxic formulation
10/20/1995CA2147344A1 Receptor expression cells and use thereof
10/19/1995WO1995027793A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICErel-II)
10/19/1995WO1995027792A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICErel-III)
10/19/1995WO1995027788A1 Polypeptide derived from variant hepatitis b virus, gene encoding the same, and related dna
10/19/1995WO1995027787A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
10/19/1995WO1995027786A1 Pharmaceutical formulations for treating japanese cedar pollen allergy
10/19/1995WO1995027784A1 Cisplatin resistance gene and uses therefor
10/19/1995WO1995027781A1 Superoxide dismutase-4
10/19/1995WO1995027736A1 Use of agents which block intercellular adhesion molecule/receptor interaction in the treatment of respiratory viral infection
10/19/1995WO1995027735A1 Apoptose inhibitor
10/19/1995WO1995027734A1 A dna molecule encoding a mast cell function-associated antigen (mafa)
10/19/1995WO1995027733A1 Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure
10/19/1995WO1995027732A2 Circularly permuted ligands and circularly permuted chimeric molecules
10/19/1995WO1995027731A1 Compound ge3
10/19/1995WO1995027730A1 New thiodepsipeptide isolated from a marine actinomycete
10/19/1995WO1995027729A1 Opiate receptor ligands
10/19/1995WO1995027728A1 Peptides
10/19/1995WO1995027723A1 Receptor modulating agents and methods relating thereto
10/19/1995WO1995027722A1 Interleukin-15
10/19/1995WO1995027518A1 Bone regeneration
10/19/1995WO1995027512A2 Compositions and methods for gene therapy to treat disease
10/19/1995WO1995027509A1 Remedy for diseases characterized by abnormal accumulation or activation of leukocyte
1 ... 2821 2822 2823 2824 2825 2826 2827 2828 2829 2830 2831 2832 2833 2834 2835 2836 2837 2838 2839 2840 2841 ... 3163